Navigation Links
Gerberding's Departure From the CDC Is No Loss
Date:1/11/2009

NEW YORK, Jan. 11 /PRNewswire-USNewswire/ -- The Committee to Reduce Infection Deaths (RID) applauds Tom Daschle's decision to appoint a new leader of the Centers for Disease Control and Prevention.

Betsy McCaughey, Ph.D., Chairman of RID, says, "The CDC is largely to blame for the huge problem of hospital infections. We have the science to prevent these infections. But CDC's lax guidelines under Gerberding have given the hospitals an excuse to do too little. The CDC is in bed with the hospital industry instead of looking out for patients."

Every year, hospital infections kill more people in the U.S. than AIDS, breast cancer, and auto accidents combined, and add $30.5 billion to the nation's health tab in unnecessary expenses. The incoming Secretary Daschle, who wants to reduce healthcare costs, should turn the CDC's attention to preventing these infections.

The CDC consistently caters to the hospital industry rather than calling for universal screening for MRSA bacteria on incoming patients, more rigorous cleaning standards in hospitals, and use of proven back-up technologies such as antibiotic-impregnated central-line catheters. "I encourage Daschle to select a CDC head who will focus on the needs of patients, rather than the hospital industry," says McCaughey.

To speak with Dr. Betsy McCaughey, please call 212-369-3329.


'/>"/>
SOURCE The Committee to Reduce Infection Deaths
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Neurochem announces departure of Dr. Philippe Calais, President, Global Business
2. Neurochem announces departure of two members of management team
3. NightHawk Radiology Holdings, Inc. Announces Board Member Departure
4. Ventas Announces Brush Departure
5. Darwin Announces Departure of Senior Vice President
6. MHS Announces Departure of Dr. Steven Friedman; Search for New Executive Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... Z-Medica, ... University of Pittsburgh Medical Center (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) ... program, developed in association with efforts by the American College of Surgeons, U.S. ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... laboratory instruments are critical to ensuring high-quality results and maintaining GMP and USP ... of Laboratory Instruments in accordance with GMP requirements " these requirements are explained. ...
(Date:3/28/2017)... ... 28, 2017 , ... With less than 10,000 dermatologists in the United States ... be limited while the desire to conquer breakouts and eliminate skincare stress is widespread. ... customer online, today released its inaugural survey on the State of Acne in America. ...
(Date:3/28/2017)... ... , ... Columbus OH. Dr. Justin Harper, Founder of Juvly Aesthetics in Ohio ... country to sit on the 2017 National Advisory Board for Allergan’s Facial Aesthetics National ... helped propel the clinic from a small start-up to number 78 in the country ...
(Date:3/28/2017)... ... March 28, 2017 , ... Public relations pros work hard to ... of business channels. , While many results are clear, much of PR is hard ... , When it comes to measurement, firms should always take an all-inclusive approach that ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... Mass. , March 28, 2017 ... company developing innovative therapeutics that address significant unmet ... a patent from the Japan Patent Office (JPO) ... connective tissue growth factor (CTGF) for the treatment ... limited to skin fibrosis and proliferative retinopathy (Japanese ...
(Date:3/28/2017)... , March 28, 2017 ... research with Cambridge ... Consortium   The Milner Therapeutics Institute today announces ... Elysium Health has committed significant investment for collaborative projects with ... next four years. This is the first major research investment ...
(Date:3/27/2017)... TEL-AVIV, Israel , March 27, 2017 /PRNewswire/ ... TASE: THXBY), a specialty clinical-stage pharmaceutical company specializing in the ... of its public offering in the ... Shares (ADSs), each ADS representing 40 ordinary shares ... per ADS. In addition, Therapix has granted the ...
Breaking Medicine Technology: